Morita Yasuyoshi

モリタヤスヨシ | Morita Yasuyoshi

Affiliation and department：
Job title： Associate Professor

Research field (1)： Hematology and oncology

Research theme for competitive and other funds (6)：

2023 - 2026 変異受容体型チロシンキナーゼの細胞内輸送制御による白血病治療薬の開発研究
2022 - 2025 治癒を目指したCML幹細胞の特性解析
2020 - 2023 多発性骨髄腫の病態形成に関わる抗腫瘍免疫機構の解析研究
2018 - 2021 Characterization molecular and immunologic features of CML stem cells for treatment-free remission.
2016 - 2019 Analysis of novel pathogenesis caused by disorder of immature hematopoietic cells in multiple myeloma

Show all

Papers (119)：

Kensuke Usuki, Toshihiro Miyamoto, Takuji Yamauchi, Kiyoshi Ando, Yoshiaki Ogawa, Masahiro Onozawa, Takahiro Yamauchi, Hitoshi Kiyoi, Akira Yokota, Takayuki Ikezoe, et al. A phase 1/2 study of NS-87/CPX-351 (cytarabine and daunorubicin liposome) in Japanese patients with high-risk acute myeloid leukemia. International journal of hematology. 2024. 119. 6. 647-659
Takahiro Haeno, Shinya Rai, Yoshiaki Miyake, Maiko Inoue, Ko Fujimoto, Aki Fujii, Yoshio Iwata, Shuji Minamoto, Takahide Taniguchi, Hiroaki Kakutani, et al. Long-term effectiveness and safety of high dose chemotherapy followed by autologous stem cell transplantation in daily practice in patients with diffuse large B-cell lymphoma. Journal of clinical and experimental hematopathology : JCEH. 2023. 63. 2. 99-107
Ryosuke Fujiwara, Yasuhiro Taniguchi, Shinya Rai, Yoshio Iwata, Aki Fujii, Ko Fujimoto, Takahiro Kumode, Kentaro Serizawa, Yasuyoshi Morita, J Luis Espinoza, et al. Chlorpromazine cooperatively induces apoptosis with tyrosine kinase inhibitors in EGFR-mutated lung cancer cell lines and restores the sensitivity to gefitinib in T790M-harboring resistant cells. Biochemical and biophysical research communications. 2022. 626. 156-166
Yasuyoshi Morita, Yasuhito Nannya, Motoshi Ichikawa, Hitoshi Hanamoto, Hirohiko Shibayama, Yoshinobu Maeda, Tomoko Hata, Toshihiro Miyamoto, Hiroshi Kawabata, Kazuto Takeuchi, et al. ASXL1 mutations with serum EPO levels predict poor response to darbepoetin alfa in lower-risk MDS: W-JHS MDS01 trial. International journal of hematology. 2022. 116. 5. 659-668
Chikashi Yoshida, Takeshi Kondo, Tomoki Ito, Masahiro Kizaki, Kazuhiko Yamamoto, Toshihiro Miyamoto, Yasuyoshi Morita, Tetsuya Eto, Yuna Katsuoka, Naoki Takezako, et al. Real-world treatment patterns and clinical outcomes in patients with AML in Japan who were ineligible for first-line intensive chemotherapy. International journal of hematology. 2022. 116. 1. 89-101

ｍore...

MISC (60)：

岩田吉生, 森田泰慶, 辻潔, 頼晋也, 田崎貴之, 井上宏昭, 谷口康博, 藤本昂, 田中宏和, 芦田隆司, et al. 脳静脈洞血栓症を合併し、開頭減圧術・術後エクリズマブ投与が有効であったPNHの一例(Post-operative treatment with eculizumab for PNH presenting as cerebral venous sinus thrombosis). 臨床血液. 2018. 59. 9. 1765-1765
堀川亮太, 頼晋也, 齋藤花往里, 森田泰慶, 田中宏和, 辰巳陽一, 芦田隆司, 松村到. 腹水貯留にて発症したprimary effusion lymphoma-like diffuse large B-cell lymphomaの1例. 臨床血液. 2017. 58. 1. 48-48
波江野高大, 頼晋也, 藤本昂, 森田泰慶, 田中宏和, 辰巳陽一, 芦田隆司, 松村到. 副腎不全を契機に診断した両側性副腎原発悪性リンパ腫の1例. 臨床血液. 2017. 58. 1. 53-53
小森舞子, 井上宏昭, 角谷宏明, 大山泰世, 森田泰慶, 芦田隆司, 松村到. アザシチジンをつなぎ治療として非血縁造血幹細胞移植を行い,2回目の再発時にアザシチジン併用ドナーリンパ球輸注を行い良好な経過を辿ったモノソミー7を有する骨髄異形成症候群. 日本造血細胞移植学会総会プログラム・抄録集. 2017. 39th
芦田隆司, 芦田隆司, 斎藤花往里, 藤本昴, 末田早苗, 角谷宏明, 大山泰世, 井上宏昭, 谷口康博, 頼晋也, et al. FLU+MELは強度減弱移植前処置として適切でない~D-indexを用いた解析~. 日本造血細胞移植学会総会プログラム・抄録集. 2017. 39th

ｍore...

Lectures and oral presentations (168)：

Gilteritinib treatment for extramedullary relapse of FLT3-ITD acute myeloid leukemia
(日本造血細胞移植学会総会プログラム・抄録集 2021)
Clinical usefulness of Letermovir for patients with stem cell transplantation
(日本造血細胞移植学会総会プログラム・抄録集 2021)
CMML様の病型移行を来したMDSに対してアザシチジンが有効であった1例
(臨床血液 2021)
Outcomes of allo-SCT for patients in non-remission especially with chemoresistance
(日本造血細胞移植学会総会プログラム・抄録集 2020)
Efficacy of dental extraction in patients with oral diseases prior to allogeneic hematopoietic stem cell transplantation
(日本造血細胞移植学会総会プログラム・抄録集 2020)

ｍore...

Education (1)：

- 現在 Kindai University Faculty of Medicine

Professional career (1)：

医学博士 (近畿大学)

Committee career (1)：

- 現在日本血液学会評議員

Association Membership(s) (3)：

THE JAPAN SOCIETY FOR TRANSPLANTATION , THE JAPANESE SOCIETY OF HEMATOLOGY , THE JAPANESE SOCIETY OF INTERNAL MEDICINE

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page